Discover the latest breakthroughs in migraine treatment for 2025, including CGRP inhibitors, AI-powered personalized plans, ...

The American College of Physicians strongly recommends adding a triptan to an NSAID to treat adults with moderate to severe ...

The American College of Physicians has released new guidelines for treating acute episodic migraines in nonpregnant adults in ...

Why are Black patients are less likely to receive migraine treatment? Here's what you need to know about seeking adequate care.

ACP released new clinical guidance on outpatient treatment of acute episodic migraine with combination therapy in patients ...

Atogepant vs placebo for the preventative treatment of migraine alleviated migraine symptoms across 3 clinical trials on day 1.

These episodes are known as migraine attacks.Migraine affects up to 12% of the global population and is the second leading ...

The American College of Physicians issues new guidance on the prevention of episodic migraine with pharmacologic treatment recommendations.

Lasmiditan is a promising treatment for menstrual migraine, offering sustained pain relief comparable to or exceeding that of triptans. However, further research is needed to fully assess its safety ...

The American College of Physicians (ACP) has developed new recommendations for treatment of acute episodic migraines in nonpregnant adults in outpatient settings.

The global market for acute migraine treatment is on a steady growth trajectory, with sales expected to rise from USD 2,700.7 million in 2024 to USD 4,194.1 million by 2034, reflecting a CAGR of 4.5% ...

DARIEN, Conn., March 6, 2025 /PRNewswire/ -- CEFALY Technology, maker of the #1 neuromodulation treatment for migraine, announced today it has selected PayrHealth, the industry's leading Complete ...